CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FO

Cumberland initiating Phase II FIGHTING FIBROSIS™ clinical trial,
Newest program in Cumberland's ifetroban pipeline
NASHVILLE, Tenn., May 23, 2023 /PRNewswire/ -- Cumberland... | May 23, 2023

Related Keywords

Vanderbilt University , Tennessee , United States , Winhealth Pharma , Nasdaq , Drug Administration , Cumberland Pharmaceuticals Inc , Cumberland Pharmaceuticals , Cumberland Emerging Technologies Inc , Life Sciences Center , Investigational New Drug Application , Idiopathic Pulmonary Fibrosis , Pulmonary Fibrosis , Systemic Sclerosis , Duchenne Muscular , Cumberland Pharmaceuticals Chief Executive , Cumberland Emerging Technologies , Oral Solution , Emerging Technologies , Launch Tennessee , Sciences Center , Cumberland Pharmaceuticals Inc Stock Exchange , News , Information , Press Release , Umberland , Initiating , Hase , Hi , Lighting , Linical , Program , N , Fetroban , Bay , 023 Cpix Us2307701092 ,